2-Amino-9-(2-β-C-methyl-β-D-ribofuranosyl)-9H-purine

Catalog No.: 
ACHXOR915
CAS No.: 
690269-87-5
Molecular Formula: 
C11H15N5O4
Molecular Weight: 
281.27
2-Amino-9-(2-β-C-methyl-β-D-ribofuranosyl)-9H-purine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%
250mg97%
1g97%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Amino-9-(2-β-C-methyl-β-D-ribofuranosyl)-9H-purine
IUPAC Name(2R,3R,4R,5R)-2-(2-amino-9H-purin-9-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol
Molecular FormulaC11H15N5O4
Molecular Weight281.27
SMILESO[C@@]1(C)[C@H](N2C=NC3=CN=C(N)N=C23)O[C@H](CO)[C@H]1O
InChI KeyVULPIDXRASQDGN-LUQPRHOASA-N
Synonym9-(2-C-Methyl-beta-D-ribofuranosyl)-9H-purin-2-amine;(2R,3R,4R,5R)-2-(2-Amino-9H-purin-9-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol;9H-Purin-2-amine, 9-(2-C-methyl-β-D-ribofuranosyl)-;2-Amino-9-(2-C-methyl-β-D-ribofuranosyl)-9H-purine;2-Ami no-9-(2-b-C-methyl-β-D-ribofuranosyl)-9H-purine;(2R,3R,4R,5R)-2-(2-Amino-purin-9-yl)-5-hydroxymethyl-3-methyl-tetrahydro-furan-3,4-diol
CAS No.690269-87-5

Synthetic Route by SureRoute

1. ACHXOR915 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEDMW612 route compound structure diagram
    ACEDMW6126108-23-2In Stock
  4. Then
  5. ACHXOR915 route product structure diagram
    ACHXOR915690269-87-5
Inquiry

2. ACHXOR915 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHXOR915 route product structure diagram
    ACHXOR915690269-87-5
Inquiry

3. ACHXOR915 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHXOR915 route product structure diagram
    ACHXOR915690269-87-5
Inquiry

Comments (0)